Top Markets
Coin of the day
Maxigen Biotech Inc. Maxigen Biotech Inc.

Maxigen Biotech Inc.

1783
Classement en actions #21087
Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development,... Maxigen Biotech Inc. (MBI) is a company dedicated to the research, development, production, and global commercialization of advanced biomedical and skincare solutions. Its extensive biomedical portfolio includes various orthopedic products such as Formagraft, a bone graft substitute, and Formasetin, a bone void filler. For intra-articular applications in orthopedics, MBI markets injections under the names ArtiAid, ArtiAid Plus, and ArtiBest. The company's offerings also span both orthopedic and dental fields, featuring Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental graft. Specifically for dental use, MBI provides FormaAid, a collagen membrane, and the E-TECH DENTISTAR II sterilizer and disinfectant. Furthermore, HealiAid, a collagen wound dressing product, serves dental and general wound care purposes. MBI also manufactures ophthalmic viscoelastic devices, known as ViscAid, PreviscAid, and BiVisc, and produces Formaderm, a dermal filler injection utilized in plastic surgery. Beyond its medical devices, Maxigen Biotech Inc. offers a comprehensive line of skincare products. This array includes masks for the face, neck, body, and limbs, alongside make-up removers, cleansers, exfoliants, toners, essences, men's grooming items, sunscreens, and specialized body, hand, and foot care formulations. Maxigen Biotech Inc. was established in 1998 and operates from its main office in Taoyuan City, Taiwan.
Prix de l'action
$1.28
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$115.23M
Changement (1 jour)
-0.25%
Changement (1 an)
-10.17%
Pays
TW
Échange Maxigen Biotech Inc. (1783)

Catégorie

Le prix 1783 avec la capitalisation boursière de B
Maxigen Biotech Inc. Maxigen Biotech Inc.
1783
$1.28
Capitalisation boursière de Maxigen Biotech Inc.(1783)
Capitalisation boursière: $115.23M
En August 2026, Maxigen Biotech Inc. a une capitalisation boursière de $115.23M. Cela fait de Maxigen Biotech Inc. la 21087th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Maxigen Biotech Inc. du 2012 au 2026
1783 par rapport au top 5 des plus populaires stocks
Prix pour 1783 L’actif B La capitalisation boursière de B Résultats
Maxigen Biotech Inc. Maxigen Biotech Inc.
$58,099.29 $115.23M
$5.211T +4,522,369.46%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$50,689.70 $115.23M
$4.547T +3,945,604.16%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$46,405.64 $115.23M
$4.162T +3,612,131.42%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$40,054.47 $115.23M
$3.593T +3,117,753.81%
Maxigen Biotech Inc. Maxigen Biotech Inc.
$31,136.32 $115.23M
$2.793T +2,423,562.31%